HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

N-(2-(2,6-Dimethoxyphenoxy)ethyl)-2,3-dihydro-1,4-benzoxathiin-2-methanamine

HCID 2325
NotesReactions
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
92642-94-9
Standard SMILES
COc1cccc(OC)c1OCCNCC1CSc2ccccc2O1
InChIKey
QAUVAHYHKLRJCQ-UHFFFAOYSA-N
Molecular formula
C19H23NO4S
Average molar mass
361.5 g/mol
Monoisotopic mass
361.13477939

Overview

RN given refers to parent cpd; structure given in first source

Names & identifiers

Preferred name
N-(2-(2,6-Dimethoxyphenoxy)ethyl)-2,3-dihydro-1,4-benzoxathiin-2-methanamine
IUPAC
N-(2,3-dihydro-1,4-benzoxathiin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamine
English name
benoxathian
Molecular formula
C19H23NO4S
Molecular weight
361.46

Names & synonyms

Benoxathian92642-94-92-(((2-(2,6-Dimethoxyphenoxy)ethyl)amino)methyl)-1,4-benzoxathianRefChem:926633N-(2-(2,6-Dimethoxyphenoxy)ethyl)-2,3-dihydro-1,4-benzoxathiin-2-methanamine1,4-benzoxathiin-2-methanamine, n-[2-(2,6-dimethoxyphenoxy)ethyl]-2,3-dihydro-1,4-Benzoxathiin-2-methanamine, N-(2-(2,6-dimethoxyphenoxy)ethyl)-2,3-dihydro-N-((2,3-Dihydrobenzo[b][1,4]oxathiin-2-yl)methyl)-2-(2,6-dimethoxyphenoxy)ethanamineBENZOXATHIANN-(2,3-dihydro-1,4-benzoxathiin-2-ylmethyl)-2-(2,6-dimethoxyphenoxy)ethanamineLopac0_000225CHEMBL191044
Show more names
BDBM86232DTXSID10919033CAS_2325NSC_2325CCG-204320SDCCGSBI-0050213.P002NCGC00015120-02NCGC00015120-03

Database identifiers

CAS
92642-94-9

Properties

Computed structural properties

XLogP
3.4
Topological polar surface area
74.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
6
Rotatable bonds
8
Heavy atoms
25
Formal charge
0
Complexity
374

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
PubChem CID
2325
DTXSID
DTXSID10919033
ChEMBL
CHEMBL191044
Nikkaji
J378.329D